Non-Clinical Development of Fixed Combinations: A European Regulatory Perspective

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.18, Iss.3, 2004-01, pp. : 135-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk Management: A European Regulatory Perspective

By Moseley J.N.S.

Drug Safety, Vol. 27, Iss. 8, 2004-01 ,pp. : 499-508

Adis International

Access to resources Recommend Favorite

Joint EFPIA/CHMP SWP workshop: the Emerging Use of Omic Technologies for Regulatory Non-Clinical Safety Testing

By Kasper Peter Oliver Gerry Lima Beatriz Silva Singer Thomas Tweats David

Pharmacogenomics, Vol. 6, Iss. 2, 2005-03 ,pp. : 181-184

Future Medicine

Access to resources Recommend Favorite

Mapping and Characterizing the Development Pathway from Non-Clinical through Early Clinical Drug Development

By Stergiopoulos Stella Getz Kenneth A.

Pharmaceutical Medicine, Vol. 26, Iss. 5, 2012-10 ,pp. : 297-307

Adis International

Access to resources Recommend Favorite

The New European Regulation on Pediatric Medicines: Regulatory Perspective

By Hawcutt Daniel B. Smyth Rosalind L.

Pediatric Drugs, Vol. 10, Iss. 3, 2008-01 ,pp. : 143-146

Adis International

Access to resources Recommend Favorite

Role of Modelling and Simulation: A European Regulatory Perspective

By Jönsson Siv Henningsson Anja Edholm Monica Salmonson Tomas

Clinical Pharmacokinetics, Vol. 51, Iss. 2, 2012-02 ,pp. : 69-76

Adis International

Access to resources Recommend Favorite